{
    "2019-05-20": [
        [
            {
                "time": "2019-05-20",
                "original_text": "格隆汇港股聚焦(5.20)︱小米一季度经调整净利润升22.4%至20.81亿元 国际市场收入同比增34.7%",
                "features": {
                    "keywords": [
                        "小米",
                        "净利润",
                        "国际市场",
                        "收入增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "复星医药：控股子公司获药品GMP证书",
                "features": {
                    "keywords": [
                        "复星医药",
                        "GMP证书",
                        "子公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "复星医药(02196.HK)子公司获抗感染药物药品GMP证书",
                "features": {
                    "keywords": [
                        "复星医药",
                        "抗感染药物",
                        "GMP证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-13",
                "original_text": "寻找强内需与科创板的最大公约数 -- 医药行业周报（2019.05.13-2019.05.19）",
                "features": {
                    "keywords": [
                        "强内需",
                        "科创板",
                        "医药行业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "营收8501亿销售费用超2000亿 A股医疗赛道还有哪些绊脚石",
                "features": {
                    "keywords": [
                        "营收",
                        "销售费用",
                        "A股",
                        "医疗"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}